Psychosocial Outcomes and Transition Readiness in Uveitis

Uveitis Clinical Trial

Official title:

Describing Relationships Between Psychosocial Outcomes and Readiness for Transition in Adolescent and Young Adult Patients With Uveitis - a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03554824
• Other study ID #: SCH-2174
• Status: Completed
• Start date: January 3, 2018
• Est. completion date: August 14, 2018

Study information

• Verified date: September 2018
• Source: Sheffield Children's NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is widely acknowledged that the transition from paediatric to adult health services should be a multidimensional and multidisciplinary process that addresses the medical, psychosocial, and educational needs of adolescents and young adults (AYA). Despite this, there is currently a scarcity of research examining the relationships between psychosocial factors (e.g., anxiety, social support) and transition readiness in AYA with uveitis. This study therefore aims to examine the relationships between psychosocial factors and transition readiness in pre-transfer adolescents and post-transfer young adults aged 10-25 years diagnosed with JIA at a single centre.

In total, 25 adolescents aged 10-16 years, together with a parent/guardian, will participate at Sheffield Children's Hospital and 10 young adults aged 16-25 years will participate at Sheffield Teaching Hospitals. Participants completed a battery of self-report questionnaire measuring psychosocial factors (anxiety/depression, social support, family functioning, health-related quality of life) and transition readiness (transition knowledge and skills, self-efficacy). Uveitis disease severity was also measured during clinic appointments. A subset of participants will also be asked to take part in a focus group. This study received full ethical approval, and all participants will give their written informed assent or consent before taking part.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: August 14, 2018
• Est. primary completion date: August 14, 2018
• Gender: All
• Age group: 10 Years to 25 Years

Eligibility

Inclusion Criteria:

• Diagnosis of uveitis

• Uveitis managed by either Sheffield Children's NHS Foundation Trust or Sheffield Teaching Hospitals NHS Foundation Trust

• Fluent in English

Exclusion Criteria:

• No diagnosis of uveitis

• Uveitis not managed by either Sheffield Children's NHS Foundation Trust or Sheffield Teaching Hospitals NHS Foundation Trust

• Not fluent in English

Related Conditions & MeSH terms

• Uveitis

Locations

Country	Name	City	State
United Kingdom	Sheffield Children's NHS Foundation Trust	Sheffield

Sponsors (2)

Lead Sponsor	Collaborator
Sheffield Children's NHS Foundation Trust	Sheffield Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Generalised Anxiety	Generalised Anxiety Disorder-7 Questionnaire (Spitzer et al., 2006)	Day 1, when participants complete the study questionnaire
Secondary	Depression	Patient Health Questionnaire-9 (Spitzer et al., 1999)	Day 1, when participants complete the study questionnaire
Secondary	Health-related quality of life	Paediatric Quality of Life Generic Module (Varni et al., 2002)	Day 1, when participants complete the study questionnaire
Secondary	Social support	Bath Adolescent Pain Questionnaire Social Support Subscale (Eccleston et al., 2005)	Day 1, when participants complete the study questionnaire
Secondary	Family functioning	Bath Adolescent Pain Questionnaire Family Functioning Subscale (Eccleston et al., 2005)	Day 1, when participants complete the study questionnaire
Secondary	Prosocial and problem behaviours	Strengths and Difficulties Questionnaire (Goodman, 1997)	Day 1, when participants complete the study questionnaire
Secondary	Uveitis disease severity	Standardization of uveitis nomenclature (SUN) scores will be used to assess uveitis disease severity.	Day 1, during hospital clinic appointment